Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 171

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Colorectal Cancer Expression of Peroxisome Proliferator-Activated Receptor γ (PPARG, PPARgamma) Is Associated With Good Prognosis

Open access
Ogino, Shuji, Shima, Kaori, Baba, Yoshifumi, Nosho, Katsuhiko, Irahara, Natsumi, Kure, Shoko, Chen, Li, Toyoda, Saori, Kirkner, Gregory J., Wang, Y. Lynn, Giovannucci, Edward L., Fuchs, Charles S.·2009·Gastroenterology

Abstract

Background & Aims The peroxisome proliferator-activated receptor-γ (PPARG) is a nuclear receptor that regulates expression of mediators of lipid metabolism and the inflammatory response. There is controversy over the pro- or anti-oncogenic effects of PPARG and little is known about how its expression correlates with prognosis in patients with colon cancer. Methods Among 470 colorectal cancer patients (stages I-IV) identified in 2 independent prospective cohorts, PPARG expression was detected in 102 tumors (22%) by immunohistochemistry. Cox proportional hazard models computed hazard ratios (HRs) of colorectal cancer-specific and overall mortalities, unadjusted and adjusted for patient characteristics and tumor molecular features, including cyclooxygenase-2 (COX-2), fatty acid synthase (FASN), KRAS, BRAF, PIK3CA, p53, p21, β-catenin, LINE-1 hypomethylation, microsatellite instability (MSI) and the CpG island methylation phenotype (CIMP). Results Compared to patients with PPARG-negative tumors, patients with PPARG-positive tumors had significantly lower overall mortality, determined by Kaplan-Meier analysis (p=0.0047), univariate Cox regression (HR 0.55; 95% confidence interval [CI], 0.37-0.84; p=0.0053) and multivariate analysis (adjusted HR 0.43; 95% CI, 0.27-0.69; p=0.0004). Patients with PPARG-positive tumors experienced a lower colorectal cancer-specific mortality (HR 0.65; 95% CI, 0.40-1.07; p=0.092), which became significant in multivariate analysis (adjusted HR 0.44; 95% CI, 0.25-0.79; p=0.0054). The relationship between PPARG and lower mortality did not appear to be significantly modified by tumor stage or the other clinical and molecular variables examined (all Pinteraction>0.05). Conclusions Tumor expression of PPARG is independently associated with longer survival of patients. PPARG expression appears to mark an indolent subset of colorectal cancers.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2008.12.048

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 171

Metadata

Authors
Ogino, S., Shima, K., Baba, Y., Nosho, K., Irahara, N., Kure, S., Chen, L., Toyoda, S., Kirkner, G. J., Wang, Y. L., Giovannucci, E. L., & Fuchs, C. S.
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2009-04
Volume
136
Issue
4
Pages
1242-1250
ISSN
0016-5085 (ISSN-L)
OpenAlex
W1970020544
Cited by
171
References
6
FWCI
2.36
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Colorectal Cancer Expression of Peroxisome Proliferator-Activated Receptor γ (PPARG, PPARgamma) Is Associated With Good Prognosis. https://app.cochat.ai/papers/10.1053/j.gastro.2008.12.048
The paper
Ogino, S., Shima, K., Baba, Y., Nosho, K., Irahara, N., Kure, S., Chen, L., Toyoda, S., Kirkner, G. J., Wang, Y. L., Giovannucci, E. L., & Fuchs, C. S. (2009). Colorectal Cancer Expression of Peroxisome Proliferator-Activated Receptor γ (PPARG, PPARgamma) Is Associated With Good Prognosis. Gastroenterology. https://doi.org/10.1053/j.gastro.2008.12.048

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.